What is Perrigo?
Founded in 1887 and headquartered in Dublin, Ireland, Perrigo operates as a dominant force in the global healthcare industry. The company specializes in the development, manufacturing, and distribution of private label over-the-counter pharmaceuticals, providing essential health products to retailers and consumers worldwide. Its business model is predicated on high-volume production, rigorous quality control, and a deep integration into the retail pharmacy supply chain. As a leader in the self-care market, Perrigo maintains a robust portfolio that spans various therapeutic categories, ensuring that affordable, high-quality healthcare remains accessible to a broad demographic. The firm's longevity is a testament to its ability to adapt to shifting consumer preferences and stringent international health standards.
How much funding has Perrigo raised?
Perrigo has raised a total of $1B across 1 funding round:
Stock Offering
$1B
Stock Issuance/Offering (2014): $1B, investors not publicly disclosed
Key Investors in Perrigo
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Perrigo?
Looking ahead, the strategic deployment of the $1B investment is expected to catalyze further expansion in the company's manufacturing capabilities and product diversification efforts. With a focus on enhancing operational efficiency and strengthening its market share in the private label sector, Perrigo is well-positioned to capitalize on the increasing demand for cost-effective healthcare alternatives. The company will likely prioritize investments in research and development to broaden its therapeutic offerings while simultaneously optimizing its global distribution network. By maintaining a disciplined approach to capital allocation, Perrigo aims to sustain its competitive advantage, ensuring that it remains a pivotal partner for retailers and a trusted provider for consumers in the global self-care market.
See full Perrigo company page
